SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-17-001145
Filing Date
2017-04-21
Accepted
2017-04-21 17:15:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422010_04212017.htm SC 13G 205459
2 JOINT FILING AGREEMENT ex991sc13g07422010_04212017.htm EX-99.1 11825
  Complete submission text file 0000921895-17-001145.txt   218830
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109
Business Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109 (858) 412-8400
Tocagen Inc (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89959 | Film No.: 17776612
SIC: 2834 Pharmaceutical Preparations